(Date:5/16/2008)...delines quickly disseminated to community physicia...thDay News) -- Partnerships between major academic...k and effective way to spread cancer treatment adv...in Philadelphia. , Most new cancer treatments a...er care is provided at community hospitals, noted ...
(Date:5/16/2008)...in some early stage cases makes therapy of little ...ay 16 (HealthDay News) -- Colon cancer patients wi...receive chemotherapy. In fact, not only does chemo... actually harm them, a new study found. , "If yo...hen you should not be treated with chemotherapy. S...
(Date:5/16/2008)...a., May 16 /PRNewswire-USNewswire/ -- The Centers ...gency for Toxic Substances and,Disease Registry (A...,Health Improvement Award for 2008. Since its 1999... Stockpile (DSNS) in the CDC Coordinating Office,f...with LMI,s Health,Systems Management group, supple...
(Date:5/16/2008)... scheduled for Pittsburgh Zoo & PPG Aquarium for M...r Life, the Medicare product,of UPMC Health Plan, ...ual,National Senior Health & Fitness Day, which ha....", National Senior Health & Fitness Day is sched...will serve as host for three events in,Pennsylvani...
Breaking Medicine News(10 mins):Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2Health News:UPMC for Life is Pennsylvania Sponsor for National Senior Health & Fitness Day 2(Date:5/16/2008)...l Mechanism May Offer Novel Approach to Blood ...EANS, May 16 /- Pharmacopei...d development of novel small,molecule therapeutics...s,Dual Acting Receptor Antagonist (DARA), showed s... in a Phase 2a study in patients with mild to,mode...
(Date:5/15/2008)... 15 /- Patients with breast or,colore...s, can expect,further treatment advances with Avas...) following new data that is being presented at th...) annual meeting in Chicago at,the end of May. Aro... which,is the premier event for cancer therapy wor...
(Date:5/15/2008)...t ASCO Showed Acceptable Tolerability Profile, ...pathy, WOODCLIFF LAKE, N.J., May 15 /PRNewswire/ ...ulin mesylate (E7389) demonstrated activity in a,h... advanced or metastatic,breast cancer, according t...l. The study also suggests that eribulin mesylate ...
(Date:5/15/2008)...emonstrated in Blacks, Hispanics/Latinos, People ...s, PARSIPPANY, N.J., May 15 /- Daiic...ed at the American Society of,Hypertension,s Twent...ew,Orleans demonstrated that the powerful combinat...omil) safely and effectively helped,patients acros...
Breaking Medicine Technology:Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Media Invitation Annual General and Special Meeting of Shareholders of Haemacure 16206 1Media Invitation Annual General and Special Meeting of Shareholders of Haemacure 16206 2Navigenics 28TM 29 Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 1702 1Navigenics 28TM 29 Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments 1702 2Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision 4447 1Study Shows the Personal Touch Is Key to Maintaining Weight Loss 16201 1Study Shows the Personal Touch Is Key to Maintaining Weight Loss 16201 2...LAR Confirms Efficacy with Either Every,Two Weeksn...7 - 7:00 am CET - New pivotal data,(RAPID 1 and RA...f,Rheumatology (EULAR) show that Cimzia (certolizu... combined with methotrexate,therapy has a rapid an...ptoms of active rheumatoid arthritis (RA) compared...
...SINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharma (T...el,Aviv Stock Exchange Exchange, proceeds with the...ddition to CF101, which is currently,in clinical t...his,weekend Can-Fite will present at the EUALR ann...study results showing effective,anti-inflammatory ...
Other Medicine Technology:Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications.
The Guidant Flextend lead is a steroid-eluting, transvenous pace/sense lead with an extendable/retractable active-fixation helix. The extendable/retractable helix design offers various lead placement
The Vitatron Impulse II lead series are silicon rubber endocardial leads specifically designed to extend the longevity of the pacemaker system by providing energy efficient pacing. The high impedance
The RZ is a small lead body profile implantable unipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model).
Medicine Products: